147 results on '"Owusu, Kent A."'
Search Results
2. 631: EVALUATION OF ACUTE ANTICOAGULATION OF CEREBRAL VENOUS THROMBOSIS
3. Anticoagulants in Use
4. Pharmacological Challenges in Neurocritical Care
5. Status Epilepticus
6. A neutrophil activation signature predicts critical illness and mortality in COVID-19
7. Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage
8. Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage
9. DEXmedetomidine compared to PROpofol in NEurocritical Care [DEXPRONE]: A multicenter retrospective evaluation of clinical utility and safety
10. Alcohol Withdrawal Syndrome in Neurocritical Care Unit: Assessment and Treatment Challenges
11. 1344: CONTINUOUS-INFUSION SEDATION LORAZEPAM VERSUS MIDAZOLAM IN CRITICALLY ILL PATIENTS
12. 631: EVALUATION OF ACUTE ANTICOAGULATION OF CEREBRAL VENOUS THROMBOSIS
13. Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases
14. Pharmacology
15. 1252: CLINICAL PATHWAY PROGRAM DEVELOPMENT: CONCEPTION TO IMPLEMENTATION
16. 284: METHYLPREDNISOLONE VERSUS USUAL CARE FOR COVID-19-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME
17. Alcohol Withdrawal Syndrome in Neurocritical Care Unit: Nicotine Replacement Therapy and Thiamine Deficiency
18. Status Epilepticus
19. Application of Cannabinoids in Neurosciences: Considerations and Implications
20. Andexanet Alfa: Considerations and Practical Applications
21. Improving Post-procedure Outcomes With Clinical Care Pathway for Enteral Access
22. Chimeric Antigen Receptor T Cells: Toxicity and Management Considerations
23. 1001: IMPACT OF A CARE SIGNATURE THYROID AND PARATHYROID SURGERY PATHWAY ON PERIOPERATIVE OUTCOMES
24. Use of droxidopa for blood pressure augmentation after acute spinal cord injury: case reports
25. 775: THROMBOLYSIS PAST 3 HOURS IN PATIENTS AGED 80 OR OLDER IS NOT ASSOCIATED WITH INCREASED RISK OF ICH
26. 744: DEXMEDETOMIDINE VERSUS PROPOFOL IN NEUROCRITICAL CARE: AN EVALUATION OF CLINICAL UTILITY AND SAFETY
27. Pharmacology
28. Blood, Blood Components, Plasma, and Plasma Products
29. Narrative Review: Addressing Covid-19 Vaccine Concerns in Special and Vulnerable Populations
30. 1252: CLINICAL PATHWAY PROGRAM DEVELOPMENT: CONCEPTION TO IMPLEMENTATION
31. 284: METHYLPREDNISOLONE VERSUS USUAL CARE FOR COVID-19-ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME
32. Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID‐19): A systematic review
33. Evaluation and Management of Seizures and Status Epilepticus
34. Abstract P27: Safety and Efficacy of Alteplase in Ischemic Stroke Patients > 80 Years of Age in the Extended Time Window
35. Pearls and Pitfalls of Introducing Ketogenic Diet in Adult Status Epilepticus: A Practical Guide for the Intensivist
36. Intermediate‐dose anticoagulation, aspirin, and in‐hospital mortality in COVID ‐19: A propensity score‐matched analysis
37. Adapting clinical pharmacy staffing models during the COVID ‐19 pandemic: Lessons learned and considerations for future disaster planning
38. 121: Sedation and Analgesia Variation in COVID-19
39. 9: Evaluation of Aerosolized Epoprostenol in COVID-19 ARDS Patients
40. Analgesia and Sedation Strategies in Mechanically Ventilated Adults with COVID‐19
41. Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage
42. Admission Rothman Index, Aspirin, and Intermediate Dose Anticoagulation Effects on Outcomes in COVID-19: A Multi-Site Propensity Matched Analysis
43. Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience
44. Intravenous brivaracetam for the management of refractory focal non-convulsive status epilepticus
45. A neutrophil activation signature predicts critical illness and mortality in COVID-19
46. Alcohol Withdrawal Syndrome in Neurocritical Care Unit: Assessment and Treatment Challenges
47. Factor Xa Inhibitor-Related Intracranial Hemorrhage
48. 752: EVALUATION OF SCHEDULED INTERMITTENT 23.4% HYPERTONIC SALINE FOR ELEVATED INTRACRANIAL PRESSURE
49. Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID‐19): A systematic review.
50. Comparison of intranasal midazolam versus intravenous lorazepam for seizure termination and prevention of seizure clusters in the adult epilepsy monitoring unit
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.